ArticleScientific reports2024
Oxygen enriched PAni-based counter electrode network toward efficient dye-sensitized solar cells (DSSCs).
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Multifunctional PVC-based metal oxide/graphene composites for high-performance DSSC counter electrodes.Scientific reports · 2026Article
- Article
- Highly sensitive hierarchically structured Si-based UV sensor-photodetectors via optimized ZnO-AlScientific reports · 2026Article
- Chemical activation of kaolin-based clay bricks as a sustainable route to enhanced mechanical and thermophysical properties.Scientific reports · 2026Article
- Conductive Polymer Thin Films for Energy Storage and Conversion: Supercapacitors, Batteries, and Solar Cells.Polymers · 2025Review
- Theoretical and experimental investigation of a CuO and graphene embedded polyethylene oxide counter electrode for efficient DSSCs.Scientific reports · 2025Article
- Green building development utilising modified fired clay bricks and eggshell waste.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dye-sensitized solar cells (DSSCs) have great potential as a renewable energy technology assisting combat climate change due to its low cost, adaptability, and sustainability. Oxygen plasma ion doping is a promising strategy to improve the capacity of a low-cost, platinum-free counter-electrodes (CEs) to absorb photons and drive high-performance DSSCs via generating an abundance of active absorption sites. In this instance, novel PAni-ZnO (PZ) composite layers were designed as a CE material and received various in-situ oxygen plasma dosages, including 0, 2, 4, 6, 8, and 10 min, to improve their physiochemical and microstructural feature for the first time, to the best of our knowledge. Physical evaluations of the microstructure, porosity, morphology, contact angle, roughness, electrical, and optical, electrochemical impedance spectroscopy (EIS) features of CEs were conducted in along with an evaluation of J-V variables. Compared to pristine CE substance, the surface nature of the modified hybrids was gradually enhanced as the plasma level rose, reaching an optimum after 8 min (i.e. 0.2 µm for average pore size and average roughness Ra = 7.21 µm). Expanded plasma treatment doses also improved PV cell performance even further: after 4 min at a plasma level, η = 5.41% was obtained, and after 6 min in a oxygen plasma environment, η = 5.81% was obtained. Mixing high energetic plasma ions increased the mobility of charge carriers in PAni composites along with lowered charge carrier recombination through generating an environment that was conducive to charge dissociation. Therefore, longer lifespans and more effective charge transfer inside the photovoltaic cell as a consequence of the increased mobility less resistive losses. In this respect, following 8 min of plasma surface modification of the PZ CE, the optimized efficiency of 6.31% and J
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.